Skip to main content

Search This Blog

Hypertension

Group meditation curbs stress, whether you do it or not: study - New York Post

Breaking News

Get link
Facebook
X
Pinterest
Email
Other Apps

Comments

Post a Comment

Popular Posts

What you don't know about high blood pressure can kill you - The Daily Herald

What you don't know about high blood pressure can kill you The Daily Herald

6 Facts About Preeclampsia You Must Know - International Business Times

6 Facts About Preeclampsia You Must Know International Business Times Preeclampsia can be a serious complication during pregnancy and here are some essential facts about the condition.

Powered by Blogger

Theme images by sandoclr

Popular Posts

Afib: Causes, Symptoms, and Treatment Options

vegetables for heart health :: Article Creator Fruits & Vegetables Help Reduce Dietary Acid, Lowers Blood Pressure And Improves Kidney And Heart Health In Patients With Hypertension Fruits & Vegetables Help Reduce Dietary Acid, Lowers Blood Pressure and Improves Kidney and Heart Health in Patients With Hypertension Doctors recommend making fruits and vegetables a foundational part of the treatment of patients with hypertension. Diets high in fruits and vegetables are found to lower blood pressure, reduce cardiovascular risk, and improve kidney health due to their base-producing effects. A new study in The American Journal of Medicine, published by Elsevier, details the findings from a five-year interventional randomized control trial. Despite ongoing efforts to improve hypertension treatment and reduce its adverse outcomes with pharmacological strategies, hypertension-related chronic kidney disease and its cardiovascular mortality ar

Diabetic vascular diseases: molecular mechanisms and therapeutic strategies

chronic disease syndrome :: Article Creator 5 Causes Of Chronic Disease Black Folks Should Consider Many chronic diseases are hitting the Black community hard. In fact, due to genetic, social, and environmental factors, certain health conditions are way more prevalent and way more severe among Black patients. From high blood pressure to diabetes, prostate cancer, and cardiovascular disease, the issues range far and wide. Fortunately, there are many things you can do to prevent and address such issues. You may not realize it, but five major causes may be leading to your issues. Not sure which ones are contributing? It's easier than you think… 1. Chronic Lack of Sleep You've probably heard it all the time. Get more sleep, at least eight hours per night, don't neglect it! But it's often easier said than done. Especially if you find yourself stressed, busy, and overwhelmed by life at large. But no matter your s

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

risk based monitoring in clinical trials :: Article Creator Cutting The Price Tag Of Clinical Trials With Risk-based Monitoring Rick Morrison Comprehend Systems In our R&amp,D innovation focus month, Rick Morrison presents the cost benefits to pharma associated with risk-based monitoring. On-site monitoring is a significant expense for pharmaceutical and biotech sponsors, accounting for up to 30 percent of the cost of a clinical trial. An extremely time-consuming and costly process, traditional site monitoring requires thousands of man hours that sponsors and CROs simply don't have to spare. A more centralized, risk-based approach can reduce the price tag of site monitoring and is actually more effective and safer for patients, because more focused data means better accuracy. In fact, the FDA has shifted its guidance over the last couple of years to encourage risk-based monitoring rather than full on-site monitoring. It's also be

New clinical trial design in precision medicine: discovery, development and direction

phase 1b clinical trial :: Article Creator Aileron Therapeutics Completes Enrollment In Cohort 2 Of The Ongoing Phase 1b Clinical Trial Evaluating LTI-03 In Idiopathic Pulmonary Fibrosis (IPF) Cohort 2 will evaluate high-dose LTI-03 (5 mg BID) Previously announced Cohort 1 data demonstrated positive trends in seven of the eight biomarkers evaluated, suggesting a potential therapeutic effect AUSTIN, Texas, Sept. 23, 2024 /PRNewswire/ -- Aileron Therapeutics, Inc. ("Aileron") (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications, today announced the completion of enrollment in Cohort 2 of the ongoing Phase 1b clinical trial of LTI-03 in IPF patients. Aileron logo (PRNewsfoto/AILERON THERAPEUTICS) The last patient was enrolled in mid-September, with a total of 24 patients enrolled in the trial. Eligibl

Late-Breaking Science Abstracts and Featured Science Abstracts From the American Heart Association’s Scientific Sessions 2023 and Late-Breaking Abstracts in Resuscitation Science From the Resuscitation Science Symposium 2023

precision clinical research :: Article Creator

2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practic

hiv vaccine trials network :: Article Creator The Quest Trial, A Paradigm Of HIV Collaborative Research Cite this article Goh, LE., McDade, H., Kinloch, S. Et al. The Quest Trial, a paradigm of HIV collaborative research. Nat Med 6, 1194 (2000). Https://doi.Org/10.1038/81251 Download citation Share this article Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative Largest Ever African HIV Vaccine Trial Opens In South Africa The South African AIDS Vaccine Initiative (SAAVI) and the HIV Vaccine Trials Network (HVTN) this week launched the African arm of a Phase IIb study utilizing Merck's adenovirus trivalent (Ad5 gag/pol/nef) vaccine. The investigators hope to enroll 3,000 HIV-negative men and women over a year, and expect the study to last fo

New generic blood pressure med approved to ease shortage - UPI News

New generic blood pressure med approved to ease shortage UPI News The FDA has approved a generic version of the high blood pressure/heart failure drug valsartan, saying the move might help ease the current medication ...

Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management

acute arterial thrombosis :: Article Creator Benefits Of Intravenous Thrombolysis In Acute Ischemic Stroke Due To CeAD Photo Credit: brgfx The following is a summary of "Intravenous Thrombolysis in Patients With Cervical Artery Dissection: A Secondary Analysis of the STOP-CAD Study," published in the September 2024 issue of Neurology by Shu et al. Cervical artery dissection (CeAD) is a major cause of ischemic stroke in younger adults, accounting for 25% of cases. Researchers conducted a retrospective study to assess the benefits and risks of intravenous thrombolysis (IVT) in patients with spontaneous CeAD and acute ischemic stroke symptoms. They analyzed data from the STOP-CAD study, including 1,653 patients with spontaneous CeAD who presented within 24 hours of acute ischemic stroke symptoms. Patients were divided into 2 groups: those who received IVT and those who did not. Association between IVT and achieving functional i

Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease

exploratory trial :: Article Creator Invivyd Announces 12-month Exploratory Data From CANOPY Phase 3 Trial Invivyd (IVVD) announced positive 12-month exploratory clinical efficacy data from the company's ongoing CANOPY Phase 3 clinical trial of pemivibart, a half-life extended investigational monoclonal antibody, for the pre-exposure prophylaxis, PrEP, of COVID-19. The exploratory clinical efficacy data from follow-up months 7-12 in CANOPY Cohort B showed a relative risk reduction of 64% in the pemivibart arm compared to placebo in the likelihood of trial participants contracting confirmed symptomatic COVID-19. Continued protection over this follow-up period, absent continued dosing, was a prespecified exploratory endpoint and, added to initial 180-day clinical efficacy observations, generated an overall 12-month protection rate of 76% following two doses of pemivibart. The safety profile of pemivibart over the 12-month study period was reassuri

The first signs of a heart attack

explain coronary circulation :: Article Creator Inside A Coronary Bypass Surgery Coronary artery disease, CAD, is a condition where the arteries that supply blood to the heart muscle become clogged and narrow, making it difficult for blood and oxygen to reach the muscles of the heart. Coronary bypass surgery is one treatment option to help restore blood flow, when other surgical procedures may not be recommended. While coronary bypass surgery does not cure the underlying cause of CAD, it can alleviate symptoms, like chest pain, fatigue, difficulty breathing, and palpitations. It is done using general anesthesia, so you will be asleep during the entire procedure. Your surgeon will make an incision in your chest to access your heart and will use a machine to take over blood flow while your heart is temporarily stopped. In some cases, minimally invasive procedures are possible, where smaller incisions are used or the heart does not need to be stoppe

Archive

November 202433
October 202494
September 202477
August 202424
July 202458
June 202465
May 202450
April 202473
March 202440
February 202468

Show more Show less

Labels

causes of sudden high blood pressure
diabetes and hypertension
high blood pressure
high blood pressure diet
Hypertension
IFTTT
low blood pressure during pregnancy
orthostatic hypotension
pulmonary hypertension
What can I eat to lower my blood pressure immediately

what causes high blood pressure
What causes hypertension
what causes low blood pressure

Show more Show less